Shares of Moderna (NASDAQ: MRNA) were trading about 4% higher as of 3:50 p.m. EST on Monday. The gains came after the biotech announced that the Canadian government had increased its order of COVID-19 vaccine candidate mRNA-1273 by 20 million doses.
Moderna's supply agreement with Canada now totals 40 million doses. The company also has significant deals to supply mRNA-1273 to the U.S., the U.K., Japan, and the European Union, as well as smaller-volume agreements with Israel and Qatar.
Image source: Getty Images.
Source Fool.com